WAY-364416 potentiates the activity of known antipsychotics, improves cognitive function Oct. 30, 2009
Cycloset induces glycemic control in type 2 diabetes patients failing thiazolidinediones Oct. 29, 2009
Preclinical studies demonstrate potential of JNJ-1930942 for treatment of cognitive dysfunction Oct. 29, 2009
Favorable preclinical evaluation of CM-2395 supports future phase I trial in schizophrenia Oct. 29, 2009
RSS